Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001586660-25-000003

Options or other derivatives

  • Director acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Golumbeski George Director 2025-11-06 Grant or award · Stock Option (right to buy) +50,000 50,000 D
Loading xslF345X05/wk-form4_1762811342.xml…